US equities
|
TSLA
$391.62
▲+5.21%
MU
$903.70
▲+2.98%
NVDA
$216.00
▲+2.39%
META
$630.56
▼-1.88%
SPCX
$146.90
▼-0.40%
AAPL
$343.91
▼-1.10%
MSFT
$532.60
▲+1.54%
INTC
$90.47
▲+4.04%
TSLA
$391.62
▲+5.21%
MU
$903.70
▲+2.98%
NVDA
$216.00
▲+2.39%
META
$630.56
▼-1.88%
SPCX
$146.90
▼-0.40%
AAPL
$343.91
▼-1.10%
MSFT
$532.60
▲+1.54%
INTC
$90.47
▲+4.04%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Danaher Corp
(NY:
DHR
)
232.97
+2.47 (+1.07%)
Official Closing Price
Updated: 4:10 PM EDT, Oct 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Danaher Corp
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Transcript: Danaher Q2 2026 Earnings Conference Call
↗
July 21, 2026
Danaher (NYSE:DHR) released second-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call...
Via
Benzinga
Topics
Earnings
Get insights into the top movers in the S&P500 index of Tuesday's pre-market session.
↗
July 21, 2026
Via
Chartmill
Danaher (NYSE:DHR) Posts Better-Than-Expected Sales In Q2 CY2026 But Stock Drops
July 21, 2026
Diversified science and technology company Danaher (NYSE:DHR) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 5.5% year...
Via
StockStory
Danaher Could Swing Over $7 Billion in Value After Earnings
↗
July 20, 2026
Earnings are back in focus on Tuesday, with a Benzinga-selected slate including Danaher Corp. (NYSE:DHR). Options pricing reveals traders are bracing for volatility, with Annaly Capital Management...
Via
Benzinga
Danaher (DHR) Q2 Earnings Report Preview: What To Look For
July 19, 2026
Diversified science and technology company Danaher (NYSE:DHR) will be reporting results this Tuesday before market hours. Here’s what you need to know. Danah...
Via
StockStory
Topics
Artificial Intelligence
1 Cash-Producing Stock with Competitive Advantages and 2 We Brush Off
July 09, 2026
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
Via
StockStory
Danaher (DHR) Stock Is Up, What You Need To Know
June 25, 2026
What Happened? Shares of diversified science and technology company Danaher (NYSE:DHR) jumped 2.8% in the morning session after its recently acquired subsidi...
Via
StockStory
3 Healthcare Stocks with Questionable Fundamentals
June 25, 2026
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have realiz...
Via
StockStory
Danaher Is Down 22% This Year. Is the Masimo Acquisition the Entry Point Investors Have Been Waiting for?
↗
June 24, 2026
The life sciences giant is transforming its diagnostics segment with its acquisition of Masimo Corporation, shifting from traditional laboratory testing into patient-connected, real-time data streams.
Via
The Motley Fool
Topics
Artificial Intelligence
Earnings
Intellectual Property
1 Profitable Stock with Promising Prospects and 2 That Underwhelm
June 23, 2026
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...
Via
StockStory
The Best Stocks to Invest $1,000 in Right Now
↗
June 22, 2026
Exploring some of the top bargains in a multi-trillion-dollar industry.
Via
The Motley Fool
Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner
June 22, 2026
From
Masimo
Via
Business Wire
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
June 15, 2026
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...
Via
StockStory
3 Reasons to Avoid DHR and 1 Stock to Buy Instead
June 12, 2026
Danaher has gotten torched over the last six months - since December 2025, its stock price has dropped 21.2% to $178.42 per share. This may have investors wo...
Via
StockStory
Stay informed with the top movers within the S&P500 index on Thursday.
↗
June 04, 2026
Via
Chartmill
Gapping S&P500 stocks in Thursday's session
↗
June 04, 2026
Via
Chartmill
SCIEX Launches the novus V55 System With SCIEX OS 5.0 Software and AI Enablement Tools
June 01, 2026
From
SCIEX
Via
Business Wire
SCIEX Advances the ZenoTOF Line With Platform-Wide Expansions in Software, Integrations, and Key Collaborations
June 01, 2026
From
SCIEX
Via
Business Wire
Research Tools & Consumables Stocks Q1 Results: Benchmarking Danaher (NYSE:DHR)
May 21, 2026
Looking back on research tools & consumables stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Danaher (NYSE:DHR) and its p...
Via
StockStory
Topics
Economy
3 Profitable Stocks We’re Skeptical Of
April 27, 2026
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...
Via
StockStory
This Stock Is Up Over 52,700% Since Founding. Should Investors Buy After Its 36% Decline?
↗
April 24, 2026
This blue chip stock has been in a multiyear slump, but things are looking up.
Via
The Motley Fool
Topics
Artificial Intelligence
Top gainers and losers in the S&P500 index during Thursday's after-hours session.
↗
April 23, 2026
Via
Chartmill
Thursday's after hours session: top gainers and losers
↗
April 23, 2026
Via
Chartmill
Discover which S&P500 stocks are making waves on Wednesday.
↗
April 22, 2026
Via
Chartmill
DHR Q1 Deep Dive: Bioprocessing Momentum and Acquisition Strategy Drive Mixed Start to 2026
April 22, 2026
Diversified science and technology company Danaher (NYSE:DHR) fell short of the market’s revenue expectations in Q1 CY2026 as sales rose 3.7% year on year to...
Via
StockStory
Danaher (DHR) Q1 2026 Earnings Call Transcript
↗
April 21, 2026
Danaher (DHR) Q1 2026 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Danaher Corp. May Be the Smartest Bet in Biotech Right Now
↗
April 21, 2026
If biotech funding continues to increase this year, Danaher could benefit.
Via
The Motley Fool
Topics
Supply Chain
Danaher (NYSE:DHR) Misses Q1 CY2026 Revenue Estimates
April 21, 2026
Diversified science and technology company Danaher (NYSE:DHR) fell short of the market’s revenue expectations in Q1 CY2026 as sales rose 3.7% year on year to...
Via
StockStory
Danaher (DHR) Q1 Earnings: What To Expect
April 19, 2026
Diversified science and technology company Danaher (NYSE:DHR) will be reporting results this Tuesday before market open. Here’s what to expect. Danaher met a...
Via
StockStory
Topics
Artificial Intelligence
AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages
April 09, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
